Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or South Carolina for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to South Carolina only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. South Carolina (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Steven Madden (NPI 1538198171)

Field	Value
Entity Type	Individual
Organization	Steven Madden
Address	222 E Medical Ln Ste 400
City	West Columbia
State	SC
ZIP	29169
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	July 3, 2006

Payer Source	Total Paid
Medicare	$4M
Medicaid	$0

Key Findings

This provider is effectively single-payer in scale: lifetime Medicare revenue is reported as $4M while Medicaid revenue is listed as none, so all documented public-pay volume comes through Medicare. That concentration means payer strategy and financial performance should be evaluated primarily against Medicare reimbursement dynamics rather than a mixed Medicaid/Medicare book of business.

Revenue is heavily concentrated in a few high-cost oncology drugs: the precomputed top three Medicare codes account for 49.7% of total Medicare revenue, led by J9271 at $1.1M (29.2% of Medicare revenue), with J9144 at $396.9K (10.3%) and J0897 at $393.1K (10.2%). This degree of concentration ties a large share of the practice’s revenue to a small set of infusible oncology agents.

The code mix is consistent with an infusion-centered hematology/oncology practice that delivers systemic cancer care rather than only consultative visits. High-revenue chemotherapy and biologic injection codes such as J9271, J9144, J9299, J9312 and J9035, together with supportive drugs like J0897 and J2506, indicate regular administration of immunotherapies, monoclonal antibodies, bone-targeted agents and growth factors in-office or in an affiliated infusion setting.

Competitive standing varies across products: for its top drug J9271 the provider ranks #149 of 1841 (92th percentile) and is described as typical, unremarkable volume for that code, whereas J0897 ranks #233 of 10057 (98th percentile) and is flagged as notably above typical national volume. Additional codes flagged as notably above typical national volume include J9035 (#31 of 1852, 98th percentile) and J2506 (#26 of 586, 96th percentile), so the practice is a high-volume national participant for several supportive and chemotherapy agents but only a typical-volume participant for some leading immunotherapies.

Visit and ancillary-service utilization points to a high-throughput clinic model: 99213 appears with 1.2K claims and $77.4K revenue and is labeled an extreme outlier, far above typical national volume, while phlebotomy and common lab codes such as 36415, 85025 and 80048 rank at the 99th–98th percentiles. Those rankings and claim counts suggest substantial in-office patient throughput with frequent lab monitoring and point-of-care specimen collection.

The practice also bills for advanced diagnostics and some radiation delivery: A9595 (piflufolastat f-18) generated $267.5K (6.9% of Medicare revenue) and 78815 (PET/CT fusion) contributed $160.9K (4.2%); both sit in the upper national percentiles (84th and 86th respectively). Presence of these imaging-specific codes alongside radiation delivery codes G6015 and G6013 indicates access to or coordination with advanced PET imaging and radiation therapy workflows, which supports a more comprehensive oncology service line.

Tenure is long-standing: the NPI was enumerated on 2006-07-03 (~20 years ago), indicating the provider has an established billing history that could reflect sustained referral patterns and operational stability. That longevity can help explain the accumulated Medicare revenue base and elevated claim volumes for routine clinic services.

From an operational and revenue-risk perspective, the pairing of Medicare-only scale and a top-three code concentration of 49.7% means the provider’s front-end finances are sensitive to Medicare reimbursement changes for a small number of high-cost injectable agents. Analysts and contract negotiators should prioritize monitoring reimbursement and utilization trends for J9271, J9144 and J0897 given their outsized share of reported Medicare revenue.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

96 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	28,200	$40	$1.1M
J9144	Injection, daratumumab, 10 mg and hyaluronidase‑fihj	11,340	$40	$396.9K
J0897	Injection, denosumab, 1 mg	21,840	$20	$393.1K
J9299	Injection, nivolumab, 1 mg	14,640	$20	$351.4K
A9595	Piflufolastat f-18, diagnostic, 1 millicurie	570	$470	$267.5K
J1930	Injection, lanreotide, 1 mg	5,760	$40	$253.4K
78815	PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.…	230	$710	$160.9K
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	430	$260	$110.8K
J9312	Injection, rituximab, 10 mg	1,720	$60	$108K
J9035	Injection, bevacizumab, 10 mg	1,680	$60	$94.1K

Showing 1–10 of 96

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 96 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. South Carolina Distribution

Steven Madden — 7 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — South Carolina

Full comparison — all codes billed, vs. state median

96 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	3	30	19,700	$40	$832K
G6015	12	10	1,610	$260	$471.7K
J9299	9	10	15,760	$20	$432K
J9144	3	10	8,460	$40	$349.4K
J1930	2	10	6,960	$40	$306.5K
J9312	21	20	2,340	$60	$193.7K
A9595	2	10	410	$460	$175.9K
J0897	11	250	2,400	$20	$91.2K
J2506	4	10	740	$80	$55.9K
77014	52	60	740	$60	$51.9K

Showing 1–10 of 96

Related Providers

Other providers that share a Tax Identification Number (TIN) with Steven Madden, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Self Regional Healthcare	SC	General Acute Care Hospital	$0	$58.8M
Lexington Health Inc	SC	General Acute Care Hospital	$0	$27.4M
Lexington County Health Services District Inc	SC	General Acute Care Hospital	$0	$19.2M
Lexington Health Inc	SC	Urgent Care Clinic/Center	$0	$8.7M
Self Medical Group	SC	Emergency Medicine Physician	$0	$6M
Lexington Health Inc	SC	Pediatric Adolescent Medicine Physician	$0	$5.7M
Lexington Health Inc	SC	Emergency Medicine Physician	$0	$4.2M
Lexington County Health Serv	SC	General Acute Care Hospital	$0	$4M
Lexington Health Inc	SC	Family Medicine Physician	$0	$4M
Lexington Health Inc	SC	Obstetrics & Gynecology Physician	$0	$3.5M

Nearby Providers

Other providers in the same ZIP code as Steven Madden, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Palmetto Infusion Services LLC	SC	Infusion Therapy Clinic/Center	$0	$93.6M
United Cerebral Palsy Of South Carolina, Inc	SC	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$15.7M
Palmetto Retina Center LLC	SC	Ophthalmology Physician	$0	$10.6M
Karen Park Family Dentistry, P.A.	SC	Dentist	$0	$4.2M
John Payne	SC	Ophthalmology Physician	$4M	$0
John Wells	SC	Ophthalmology Physician	$3.9M	$0
Lexington Treatment Specialists LLC	SC	Methadone Clinic	$76.7K	$3.6M
Vijaya Korrapati	SC	Hematology & Oncology Physician	$3.4M	$0
Perrie Ryan	SC	Hematology & Oncology Physician	$3.3M	$0
William Clark	SC	Ophthalmology Physician	$3.3M	$0

Steven Madden — Billing Profile & Reimbursement Data

Sign up for Steven Madden — Billing Profile & Reimbursement Data policy alerts

Steven Madden — Billing Profile & Reimbursement Data

Sign up for Steven Madden — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References